Milestone Scientific financials
$0.41000.00%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.8M | $2.2M | $2.1M | $2.4M | $2.3M | $2.2M | $2.0M | $2.5M | $1.9M | $2.2M | $2.3M | $2.1M |
| Gross profit | $1.9M | $1.6M | $1.5M | $1.6M | $1.6M | $1.6M | $1.5M | $1.8M | $1.4M | $1.7M | $1.5M | $1.5M |
| Gross margin | 67.2% | 72.3% | 73.0% | 69.5% | 69.6% | 73.8% | 75.0% | 73.0% | 76.1% | 74.5% | 66.8% | 73.0% |
| Operating income | -$1.1M | -$828.1K | -$1.1M | -$1.1M | -$1.5M | -$2.0M | -$2.0M | -$1.5M | -$1.8M | -$1.5M | -$2.0M | -$1.5M |
| Net income | -$1.1M | -$839.9K | -$1.1M | -$1.2M | -$1.5M | -$2.0M | -$2.0M | -$1.5M | $223.6K | -$1.4M | -$1.9M | -$1.5M |
| Net margin | −37.3% | −38.8% | −53.0% | −48.9% | −63.8% | −89.3% | −101.1% | −58.1% | 12.1% | −64.1% | −85.8% | −71.2% |
| Diluted EPS | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.02 | $-0.02 | $-0.03 | $-0.02 | $0.00 | $-0.02 | $-0.03 | $-0.02 |
| EBITDA | -$1.0M | -$808.6K | -$1.1M | -$1.1M | -$1.5M | -$2.0M | -$2.0M | -$1.5M | -$1.8M | -$1.5M | -$2.0M | -$1.5M |
| Operating cash flow | -$585.1K | $86.8K | -$226.1K | $81.8K | -$1.8M | -$1.0M | -$1.5M | -$973.9K | $783.7K | -$1.2M | -$1.2M | -$1.1M |
| Free cash flow | -$589.3K | $85.2K | -$229.2K | $75.5K | -$1.8M | -$1.0M | -$1.5M | -$973.9K | $777.1K | -$1.2M | -$1.3M | -$1.1M |
| Diluted shares | 93.1M | 85.0M | 82.0M | 82.3M | 82.0M | 81.9M | 79.5M | 80.0M | 80.0M | 79.7M | 72.9M | 73.7M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.1M | $1.2M | $1.1M | $1.3M | $1.3M | $2.2M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $513.8K | $851.3K | $854.7K | $858.1K | $861.5K | $64.9K |
| Total assets | $8.3M | $8.0M | $7.8M | $8.5M | $8.1M | $9.1M |
| Total liabilities | $4.9M | $5.7M | $5.0M | $5.9M | $4.7M | $4.6M |
| Shareholders' equity | $3.5M | $2.3M | $2.8M | $2.5M | $3.3M | $4.5M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology